The Canadian Task Force on Preventive Health Care has been criticised for focusing breast cancer screening on women at ‘average risk’, leaving out high-risk categories. Critics argue that random controlled trials, considered the gold standard of evidence, aren’t effective in assessing interventions’ potential. Previously ignored non-trial studies and data modelling should be used to fill existing data gaps. It’s crucial to strike a balance between benefits and harms of screening, reflecting individual values, without downplaying screening benefits.
Health Tech | Safeguarding health: Navigating the complex landscape of cybersecurity in healthcare | News
The integration of technology in healthcare, while beneficial, has increased the sector’s vulnerability to cyber threats. Cybercriminals target healthcare data due to its high value,
